WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs

More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its dominance in the GLP-1 market.

Raccontata dacnbc.comupi.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo9 mesi fa

Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs

More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its dominance in the GLP-1 market.

originale
upi.com9 mesi fa

Eli Lilly announces planned $6.5B biomanufacturing plant in Houston - UPI.com

Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ 4,000+ in the greater Houston area.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 settembre 2025·cnbc.com

    Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs

    More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its dominance in the GLP-1 market.

  2. martedì 23 settembre 2025·upi.com

    Eli Lilly announces planned $6.5B biomanufacturing plant in Houston - UPI.com

    Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ 4,000+ in the greater Houston area.